NO20054911L - Fremgangsmate for fremstilling av et polymorft frosiglitazonmaleat - Google Patents

Fremgangsmate for fremstilling av et polymorft frosiglitazonmaleat

Info

Publication number
NO20054911L
NO20054911L NO20054911A NO20054911A NO20054911L NO 20054911 L NO20054911 L NO 20054911L NO 20054911 A NO20054911 A NO 20054911A NO 20054911 A NO20054911 A NO 20054911A NO 20054911 L NO20054911 L NO 20054911L
Authority
NO
Norway
Prior art keywords
maleate
frosiglitazone
polymorphous
preparing
compound
Prior art date
Application number
NO20054911A
Other languages
English (en)
Norwegian (no)
Inventor
Robert Gordon Giles
Michael John Sasse
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20054911L publication Critical patent/NO20054911L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20054911A 2003-03-28 2005-10-24 Fremgangsmate for fremstilling av et polymorft frosiglitazonmaleat NO20054911L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307259.2A GB0307259D0 (en) 2003-03-28 2003-03-28 Process
PCT/GB2004/001306 WO2004085435A1 (en) 2003-03-28 2004-03-25 Process for preparing a polymorph of rosiglitazone maleate

Publications (1)

Publication Number Publication Date
NO20054911L true NO20054911L (no) 2005-10-24

Family

ID=9955778

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054911A NO20054911L (no) 2003-03-28 2005-10-24 Fremgangsmate for fremstilling av et polymorft frosiglitazonmaleat

Country Status (18)

Country Link
US (1) US20070167494A1 (es)
EP (1) EP1615918A1 (es)
JP (1) JP2006521340A (es)
KR (1) KR20050120670A (es)
CN (1) CN1768057A (es)
AU (2) AU2004224068A1 (es)
BR (1) BRPI0408752A (es)
CA (1) CA2520249A1 (es)
EA (1) EA009331B1 (es)
EC (1) ECSP056038A (es)
GB (1) GB0307259D0 (es)
IS (1) IS8087A (es)
MA (1) MA27727A1 (es)
MX (1) MXPA05010413A (es)
NO (1) NO20054911L (es)
OA (1) OA13042A (es)
WO (1) WO2004085435A1 (es)
ZA (1) ZA200507100B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
WO2018140092A1 (en) 2017-01-27 2018-08-02 Obrien Christopher F Methods for the administration of certain vmat2 inhibitors
ES3024958T3 (en) 2017-09-21 2025-06-05 Neurocrine Biosciences Inc High dosage valbenazine formulation and compositions, methods, and kits related thereto
JP2021502959A (ja) 2017-10-10 2021-02-04 ニューロクライン バイオサイエンシーズ,インコーポレイテッド 特定のvmat2インヒビターを投与するための方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
UA67844C2 (uk) * 1999-04-23 2004-07-15 Смітклайн Бічам Плс Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
PL351685A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Novel pharmaceutical
DE60004658T2 (de) * 1999-04-23 2004-06-24 Smithkline Beecham Plc, Brentford Thiazolidindionderivat und seine verwendung als antidiabetikum
CZ2003864A3 (cs) * 2000-09-26 2004-01-14 Dr. Reddy´S Research Foundation Nové polymorfní formy 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl]thiazolidin-2,4-dion-maleátu a způsob jejich přípravy

Also Published As

Publication number Publication date
OA13042A (en) 2006-11-10
IS8087A (is) 2005-10-24
EA200501527A1 (ru) 2006-02-24
EA009331B1 (ru) 2007-12-28
CN1768057A (zh) 2006-05-03
MXPA05010413A (es) 2005-11-04
BRPI0408752A (pt) 2006-03-28
ZA200507100B (en) 2006-07-26
KR20050120670A (ko) 2005-12-22
AU2008237610A1 (en) 2008-11-27
US20070167494A1 (en) 2007-07-19
JP2006521340A (ja) 2006-09-21
AU2004224068A1 (en) 2004-10-07
WO2004085435A1 (en) 2004-10-07
EP1615918A1 (en) 2006-01-18
CA2520249A1 (en) 2004-10-07
MA27727A1 (fr) 2006-01-02
ECSP056038A (es) 2006-01-27
GB0307259D0 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
EA200701358A1 (ru) Кристаллические формы гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1h-3-бензазепина
NO20022558L (no) 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor
TNSN06069A1 (en) Polymorphous forms of rifaximin as antibiotics
AP1830A (en) Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same.
NO20054852L (no) GFAT inhibitorer
EP2258711A3 (en) New forms of 5-azacytidine
IL183700A0 (en) Process for production of (4,5-dihydroisoxazol-3-yl)thio-carboxamidine salts
NO20054911L (no) Fremgangsmate for fremstilling av et polymorft frosiglitazonmaleat
ZA200801890B (en) Novel crystalline form of a pyridazino (4, 5-B) indole derivative
WO2004043920A8 (en) Polymorphs of bicifadine hydrochloride
CA2678125C (en) Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride
NO20051047L (no) Fremgangsmate og mellomprodukter for fremstilling av tienopyrrolderivater
WO2002092602A3 (en) PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-[2,3-f] QUINOLINE
WO2007064478A3 (en) Method for making nicotine hapten
MXPA04005305A (es) Nuevo polimorfo cristalino de clorhidrato de venlafaxina y metodos para preparacion del mismo.
AU2003252467A1 (en) Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
IL163520A0 (en) Process for preparing crystalline form i of cabergoline
AU2002358989A1 (en) Acetyl l-carnitine salt with a dicarboxilic organic acid and process for preparing same
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
SG149005A1 (en) Process for the preparation of thiazolopyrimidines
IL163779A0 (en) Process for preparing crystalline form i of cabergoline
NO20043988L (no) Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner
IL158641A0 (en) Process for preparing a thiazole ppar-ligand and polymorphs thereof
WO2004096765A3 (en) A novel crystalline polymorph of fluvastatin sodium and a process for preparing it
AU2003219423A1 (en) Process for the isolation of high purity crystalline citalopram base

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application